Brochure
11 Nov 2023

Ethics Approval - Phase III Efficacy Clinical Trial

PDF 231 kB

Ethics Approval granted for significant Ultra Pure Synthetic CBD Phase III Efficacy Clinical Trial

Content provided by our supplier

Chanelle McCoy Health

  • Country/Region:
    Ireland
  • Founded:
    2018
  • On CPHI since:
    2020
  • Certificates:
    1
  • Employees:
    1 - 24
Company types
Consumer Goods
Licensee
Pharmaceutical company
Wholesale/Retail
Primary activities
Cosmeceuticals
Finished Formulation products Distributor/Buyer
Nutraceuticals
Pharmaceutical Company (innovator finished products)

Other Content from Chanelle McCoy Health (1)

  • News WORLD FIRST APPROVAL CHANELLE MCCOY HEALTH

    Chanelle McCoy Health has become the first and only company in the world to secure regulatory approval for CBD as an oral food supplement, with a recent approval by the Saudi Food and Drug Authority, while also becoming the first company globally to receive confirmation from European regulators that it’s CBD product is safe for use as a food supplement under the EU Novel Food guidelines.